GET DAILY SIGNALSAflac (AFL) Q3 Earnings Show Strong U.S. Margin Expansion Despite Japan Headwinds and Portfolio Losses
Key Takeaways
- Adjusted diluted EPS (earnings per share) came in at $2.43, well above the $1.80 consensus estimate, helped by reserve remeasurement gains and a stronger U.S. segment.
- Adjusted earnings fell 8.5% to $1.2 billion, while GAAP (Generally Accepted Accounting Principles) net earnings tumbled 81.5% to $303 million, or $0.61 per diluted share, on a $1.1 billion portfolio-repositioning loss.
- Aflac U.S. pretax adjusted earnings rose 31.5% to $493 million, while Aflac Japan pretax adjusted earnings declined 15.2% in yen terms.
- Management raised its 2026 Aflac Japan pretax profit-margin outlook to 35%–38% and pointed to roughly $1 billion of potential capital release through reinsurance.
- The company returned $1.1 billion to shareholders and declared a fourth-quarter dividend of $0.61 per share.
- For more context, explore Aflac's Major News, Today's Price Move, Price Targets, and Forecast on Tickeron.
- Discover Trending AI Robots to see how AI-driven trading strategies are navigating current market conditions.
Why These Results Stand Out
Aflac Incorporated operates as a major player in supplemental health and life insurance, anchored by its Aflac U.S. business in accident, cancer, and voluntary benefits alongside Aflac Japan’s leading position in the Japanese cancer-insurance market. The third-quarter 2026 release stands out because it highlights resilient core operations even as one-time investment moves create noise in the headline numbers. From what I see, this quarter serves as a useful test of whether AFL can maintain momentum in the U.S. while handling yen fluctuations, cybersecurity spending, and actuarial shifts in Japan. With shares near multi-year highs ahead of the report, attention naturally turned to margins, capital plans, and any updates on forward guidance.
Breaking Down the Quarter
For the period ended September 30, 2026, AFL delivered adjusted diluted EPS of $2.43, clearing the consensus mark of $1.80 by roughly $0.62. Adjusted revenues reached about $4.3 billion, a touch above the roughly $4.2 billion expected, though down around 9% from $4.74 billion in the prior-year quarter. Adjusted earnings slipped 8.5% to $1.2 billion, supported in part by roughly $453 million in reserve remeasurement gains. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
GAAP results looked much softer. Net earnings dropped 81.5% to $303 million, or $0.61 per diluted share, after a $1.1 billion investment loss tied mainly to portfolio repositioning, including an extra $2.3 billion switch trade in Japanese government bonds. A $51 million tax valuation allowance added further pressure to the reported figure.
Segment performance showed clear contrasts. Aflac U.S. pretax adjusted earnings climbed 31.5% to $493 million, with net earned premiums rising 3.3% to roughly $1.5 billion and the pretax margin expanding to 27.7%. Aflac Japan pretax adjusted earnings declined 15.2% to ¥152.3 billion, and its margin narrowed to 44.4% from 52.2%, reflecting higher benefits and added cybersecurity costs.
How the Market Is Reading the Print
Investor sentiment ahead of the release was measured yet generally positive. Analysts had set a relatively low EPS bar, anticipating investment losses and Japan cost pressures. Shares of AFL had gained about 12.5% year to date, ahead of the broader market, and were trading near the 52-week high even with mixed analyst views. The sizable adjusted EPS beat, fueled by reserve gains and a firmer U.S. margin, should register as constructive with investors, though the GAAP investment loss will draw scrutiny. The central question now centers on whether the upgraded Japan margin outlook and reinsurance-related capital release can offset near-term earnings drag from repositioning and cybersecurity spending.
What to Watch Going Forward
Attention will now shift to execution on the updated guidance. Management lifted its 2026 Aflac Japan pretax margin target to 35%–38%, indicating confidence even after the recent cyber event and higher benefit costs. In the U.S., the pretax margin is now projected to finish above the prior 17%–20% band, reflecting the recent strength.
Capital management stays front and center. Aflac ceded roughly ¥500 billion of cancer-policy reserves to Aflac Re Bermuda, which management expects could free up about $1 billion in capital over time while trimming risk and improving balance-sheet efficiency. The timing and use of that capital will be monitored closely.
Additional items to track include the path of the U.S. benefit ratio, yen exchange-rate effects on Japan earnings, and whether the repositioning produces the anticipated boost to annual net investment income. AFL reported an estimated regulatory solvency margin ratio of 225% and combined risk-based capital above 575%, pointing to a solid capital position. The firm also returned $1.1 billion to shareholders via buybacks and dividends, reinforcing its focus on returning capital even in a quarter with notable one-time items.
My Take on Using Tickeron Tools
When reviewing earnings like these, I often turn to Tickeron’s AI Screener to quickly compare AFL against peers on technical patterns and fundamentals. It helps surface sector context without spending hours on manual screens, and the customizable filters make it straightforward to check insurance names alongside broader market signals.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for AFL turns positive, indicating new upward trend
AFL saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned positive. In 49 of the 77 cases, the stock moved higher in the following days. The odds of a move higher are at 64%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for AFL just turned positive on October 07, 2026. Looking at past instances where AFL's MACD turned positive, the stock continued to rise in 24 of 46 cases over the following month. The odds of a continued upward trend are 52%.
AFL moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AFL crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +0.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFL advanced for three days, in 198 of 364 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The Aroon Indicator entered an Uptrend today. In 141 of 277 cases where AFL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 51%.
Bearish Trend Analysis
The 10-day RSI Indicator for AFL moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 18 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
AFL broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 31 (best 1 - 100 worst), indicating outstanding price growth. AFL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.052) is normal, around the industry mean (1.354). P/E Ratio (13.323) is within average values for comparable stocks, (20.301). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (0.463). Dividend Yield (0.020) settles around the average of (0.047) among similar stocks. AFL's P/S Ratio (3.313) is slightly higher than the industry average of (1.303).
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of supplemental life and health insurance services
Industry LifeHealthInsurance
Advertisement